Anti-CCR5/CXCR4 sheep monoclonal antibody - KS Biomedix Holdings
Alternative Names: Anti-CCR5/CXCR4; Anti-CCR5/CXCR4 MAbLatest Information Update: 27 Sep 2002
At a glance
- Originator KS Biomedix Holdings; Nonindustrial source
- Class Antivirals; Monoclonal antibodies
- Mechanism of Action CCR5 receptor antagonists; CXCR4 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued HIV-1 infections
Most Recent Events
- 27 Sep 2002 Discontinued - Preclinical for HIV-1 infections in France (unspecified route)
- 27 Sep 2002 Discontinued - Preclinical for HIV-1 infections in United Kingdom (unspecified route)
- 19 Oct 2000 Anti-CCR5/CXCR4 sheep monoclonal antibodies are available for licensing (http://www.ksbiomedix.com)